FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045110761> ?p ?o ?g. }

• W2045110761 endingPage "167" @default.
• W2045110761 startingPage "162" @default.
• W2045110761 abstract "Objective Tamoxifen has antiestrogenic effects in the breast and estrogenlike activity in the skeletons of post-menopausal women. We hypothesized that post-menopausal women with breast cancer would experience a rapid decline in bone mineral density (BMD) after stopping tamoxifen, similar to that seen with estrogen withdrawal. The objective of this study was to assess, in a randomized, double-blind, placebo-controlled trial, whether administration of alendronate (70 mg weekly) would prevent bone loss associated with tamoxifen discontinuation. Methods Postmenopausal women with breast cancer were randomly assigned to receive alendronate or placebo for 1 year within 3 months after withdrawal of tamoxifen therapy. We initiated a randomized, double-blind, placebo-controlled trial of alendronate (70 mg weekly) in an effort to prevent bone loss associated with discontinuation of tamoxifen therapy. Patients treated with aromatase inhibitors were excluded from the study. BMD at the spine, hip, and forearm was measured at baseline and at 12 months. Analyses employed repeated-measures analysis of variance. Results Patient accrual was considerably limited by the substantial increase in use of aromatase inhibitors during the enrollment period. The study patients (N = 11) had similar baseline BMD T-scores in the alendronate (n = 6) and placebo (n = 5) subgroups. After 1 year, tamoxifen withdrawal was associated with a significant decline in BMD at the femoral neck, which appeared to be prevented by weekly administration of alendronate (-5.2% versus 0.1%; P = .02). Levels of urinary N-telopeptide, a marker of bone turnover, increased by 48% in study subjects in the placebo group (P < .01), whereas weekly alendronate treatment was associated with a 52% decline (P < .01) in this bone resorption marker. Conclusion Differences in BMD and bone turnover were evident despite the small sample size. These data suggest that postmenopausal women with breast cancer completing tamoxifen therapy warrant an evaluation of their skeletal health and that bisphosphonate therapy may be useful in preventing bone loss associated with discontinuation of tamoxifen. (Endocr Pract. 2008;14:162-167)" @default.
• W2045110761 created "2016-06-24" @default.
• W2045110761 creator A5023085493 @default.
• W2045110761 creator A5024594731 @default.
• W2045110761 creator A5035840859 @default.
• W2045110761 creator A5042971986 @default.
• W2045110761 creator A5059588961 @default.
• W2045110761 creator A5069190482 @default.
• W2045110761 creator A5085274669 @default.
• W2045110761 creator A5091772334 @default.
• W2045110761 date "2008-03-01" @default.
• W2045110761 modified "2023-09-27" @default.
• W2045110761 title "Prevention of Bone Loss After Withdrawal of Tamoxifen" @default.
• W2045110761 cites W120963284 @default.
• W2045110761 cites W1936024593 @default.
• W2045110761 cites W1976680910 @default.
• W2045110761 cites W1981476886 @default.
• W2045110761 cites W1989622431 @default.
• W2045110761 cites W200263122 @default.
• W2045110761 cites W2040223224 @default.
• W2045110761 cites W2051399396 @default.
• W2045110761 cites W2102667542 @default.
• W2045110761 cites W2121099142 @default.
• W2045110761 cites W2127677509 @default.
• W2045110761 cites W2135255625 @default.
• W2045110761 cites W2142739119 @default.
• W2045110761 cites W2151447010 @default.
• W2045110761 cites W2159858973 @default.
• W2045110761 cites W2163688875 @default.
• W2045110761 cites W2168772783 @default.
• W2045110761 cites W2255137252 @default.
• W2045110761 doi "https://doi.org/10.4158/ep.14.2.162" @default.
• W2045110761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3140137" @default.
• W2045110761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18308653" @default.
• W2045110761 hasPublicationYear "2008" @default.
• W2045110761 type Work @default.
• W2045110761 sameAs 2045110761 @default.
• W2045110761 citedByCount "12" @default.
• W2045110761 countsByYear W20451107612012 @default.
• W2045110761 countsByYear W20451107612013 @default.
• W2045110761 countsByYear W20451107612014 @default.
• W2045110761 countsByYear W20451107612015 @default.
• W2045110761 countsByYear W20451107612019 @default.
• W2045110761 countsByYear W20451107612022 @default.
• W2045110761 countsByYear W20451107612023 @default.
• W2045110761 crossrefType "journal-article" @default.
• W2045110761 hasAuthorship W2045110761A5023085493 @default.
• W2045110761 hasAuthorship W2045110761A5024594731 @default.
• W2045110761 hasAuthorship W2045110761A5035840859 @default.
• W2045110761 hasAuthorship W2045110761A5042971986 @default.
• W2045110761 hasAuthorship W2045110761A5059588961 @default.
• W2045110761 hasAuthorship W2045110761A5069190482 @default.
• W2045110761 hasAuthorship W2045110761A5085274669 @default.
• W2045110761 hasAuthorship W2045110761A5091772334 @default.
• W2045110761 hasBestOaLocation W20451107612 @default.
• W2045110761 hasConcept C121608353 @default.
• W2045110761 hasConcept C126322002 @default.
• W2045110761 hasConcept C126894567 @default.
• W2045110761 hasConcept C142724271 @default.
• W2045110761 hasConcept C168563851 @default.
• W2045110761 hasConcept C204787440 @default.
• W2045110761 hasConcept C27081682 @default.
• W2045110761 hasConcept C2776067312 @default.
• W2045110761 hasConcept C2776541429 @default.
• W2045110761 hasConcept C2776886416 @default.
• W2045110761 hasConcept C2777176818 @default.
• W2045110761 hasConcept C2778715236 @default.
• W2045110761 hasConcept C530470458 @default.
• W2045110761 hasConcept C71924100 @default.
• W2045110761 hasConceptScore W2045110761C121608353 @default.
• W2045110761 hasConceptScore W2045110761C126322002 @default.
• W2045110761 hasConceptScore W2045110761C126894567 @default.
• W2045110761 hasConceptScore W2045110761C142724271 @default.
• W2045110761 hasConceptScore W2045110761C168563851 @default.
• W2045110761 hasConceptScore W2045110761C204787440 @default.
• W2045110761 hasConceptScore W2045110761C27081682 @default.
• W2045110761 hasConceptScore W2045110761C2776067312 @default.
• W2045110761 hasConceptScore W2045110761C2776541429 @default.
• W2045110761 hasConceptScore W2045110761C2776886416 @default.
• W2045110761 hasConceptScore W2045110761C2777176818 @default.
• W2045110761 hasConceptScore W2045110761C2778715236 @default.
• W2045110761 hasConceptScore W2045110761C530470458 @default.
• W2045110761 hasConceptScore W2045110761C71924100 @default.
• W2045110761 hasIssue "2" @default.
• W2045110761 hasLocation W20451107611 @default.
• W2045110761 hasLocation W20451107612 @default.
• W2045110761 hasLocation W20451107613 @default.
• W2045110761 hasLocation W20451107614 @default.
• W2045110761 hasOpenAccess W2045110761 @default.
• W2045110761 hasPrimaryLocation W20451107611 @default.
• W2045110761 hasRelatedWork W1563200977 @default.
• W2045110761 hasRelatedWork W2036296292 @default.
• W2045110761 hasRelatedWork W2075397429 @default.
• W2045110761 hasRelatedWork W2087128925 @default.
• W2045110761 hasRelatedWork W2095497928 @default.
• W2045110761 hasRelatedWork W2124861559 @default.
• W2045110761 hasRelatedWork W2796154413 @default.
• W2045110761 hasRelatedWork W3162303886 @default.

• next